SMMT
NASDAQ · Biotechnology
Summit Therapeutics Inc
$13.96
+0.42 (+3.10%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-6.75%
1Y
-51.29%
YTD
-20.32%
Open$13.90
Previous Close$13.54
Day High$14.02
Day Low$13.52
52W High$30.05
52W Low$12.25
Volume—
Avg Volume4.21M
Market Cap11.14B
P/E Ratio—
EPS$-1.12
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.75
Below
SMA 200
$20.83
Below
RSI (14)
54
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
24 analysts
Price Target
+1,304.6% upside
Current
$13.96
$13.96
Target
$196.08
$196.08
$141.53
$196.08 avg
$244.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.10B | 1.08B | 883.89M |
| Net Income | 169.72M | 168.86M | 142.65M |
| Profit Margin | 15.4% | 15.6% | 16.1% |
| EBITDA | 286.46M | 306.19M | 235.37M |
| Free Cash Flow | 170.10M | 157.58M | 108.43M |
| Rev Growth | -3.6% | +10.5% | -9.8% |
| Debt/Equity | 1.16 | 1.05 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |